Iproniazid (Euphozid Iprazid Ipronid Ipronin Marsilid Rivivol) is a hydrazine drug used as an antidepressant. It acts as an irreversible and nonselective monoamine oxidase inhibitor (MAOI). Though it has been widely discontinued in most of the world it is still used in France. As with all MAOIs iproniazid is contraindicated in patients using SSRIs SRAs and serotonin agonists.
This page contains content from the copyrighted Wikipedia article "Iproniazid"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
